USE OF MITOXANTRONE LIPOSOME FOR TREATING NON-HODGKIN'S LYMPHOMA
Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymph...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
15.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed is a use of a liposomal pharmaceutical preparation of mitoxantrone in the preparation of a medicament for treating lymphoma, wherein the lymphoma is preferably non-Hodgkin's lymphoma, further preferably aggressive non-Hodgkin's lymphoma, more preferably diffuse large B-cell lymphoma or peripheral T-cell lymphoma, and more further preferably relapsed or refractory diffuse large B-cell lymphoma or peripheral T-cell lymphoma. The mitoxantrone liposomes are used as single anti-tumor therapeutic agent without being combined with other anti-tumor agents. |
---|---|
Bibliography: | Application Number: EP20190833348 |